03 Mar 2021

NIH pauses Covid-19 convalescent plasma trial

The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as the study provided no significant…

02 Mar 2021

CRUK teams up with Teon to trial first-in-class cancer drug

Cancer Research UK (CRUK) has signed a clinical development collaboration with California-based Teon Therapeutics. Teon’s work focuses on developing a portfolio of immunotherapies for cancer that modulates and antagonises metabolic…